Back
Relay Therapeutics Quote, Financials, Valuation and Earnings
Big Gains Still to Be Had in 2023
Grab a FREE ticket right now on this page!
Buy
58
RLAY
Relay Therapeutics
Last Price:
11.01
Seasonality Move:
8.05%
7 Day Trial
ALL ACCESS PASS
$
7
This A.I. system is like having 100k financial analysts on hand
Get here to get the full storyRelay Therapeutics Price Quote
$11.01
-0.02 (7.73%)
(Updated: September 2, 2023 at 6:20 AM ET)
Relay Therapeutics Key Stats
Buy
58
Relay Therapeutics (RLAY)
is a Buy
Day range:
$10.33 - $11.06
52-week range:
$9.67 - $33.06
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,390.37
P/B ratio:
1.66%
Volume:
1.5M
Avg. volume:
794.2K
1-year change:
-55.7%
Market cap:
$1.3B
Revenue:
$1.4M
EPS:
$-2.91
How Much Does Relay Therapeutics Make?
-
How Much Are Relay Therapeutics's Sales Annually?
RLAY Revenues are $1.4M -
How Much Profit Does Relay Therapeutics's Make A Year?
RLAY net income is -$290.5M
Is Relay Therapeutics Growing As A Company?
-
What Is Relay Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.67% -
What Is Relay Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Relay Therapeutics Stock Price Performance
-
Did Relay Therapeutics Stock Go Up Last Month?
Relay Therapeutics share price went down by -7.39% last month -
Did RLAY's Share Price Rise Over The Last Year?
RLAY share price fell by -55.7% over the past 1 year
What Is Relay Therapeutics 52-Week High & Low?
-
What Is Relay Therapeutics’s 52-Week High Share Price?
Relay Therapeutics has traded as high as $33.06 over the past 52 weeks -
What Is Relay Therapeutics’s 52-Week Low Share Price?
Relay Therapeutics has traded as low as $9.67 over the past 52 weeks
Relay Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Relay Therapeutics?
-
How Much Debt Does Relay Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Relay Therapeutics Have?
Cash and short term investments quarterly total is $871.6M -
What Is Relay Therapeutics’s Book Value Per Share?
Book value per share is 6.64
Is Relay Therapeutics Cash Flow Positive?
-
What Is RLAY Cash Flow From Operations?
Cash flow from operations (TTM) is -$259M -
What Is Relay Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $290.4M -
What Is Relay Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $6.8M
Relay Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
RLAY return on invested capital is -38.93% -
What Is Relay Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -33.39% -
What Is RLAY Return On Equity?
ROE is a measure of profitability and is -38.93%
Relay Therapeutics Earnings Date & Stock Price
-
What Is Relay Therapeutics's Stock Price Today?
A single share of RLAY can be purchased today for 11.03 -
What Is Relay Therapeutics’s Stock Symbol?
Relay Therapeutics trades on the nasdaq under the ticker symbol: RLAY -
When Is Relay Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Relay Therapeutics is scheduled on November 3, 2023 -
When Is RLAY's next ex-dividend date?
Relay Therapeutics's next ex-dividend date is September 4, 2023 -
How To Buy Relay Therapeutics Stock?
You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Relay Therapeutics Competitors
-
Who Are Relay Therapeutics's Competitors?
Below is a list of companies who compete with Relay Therapeutics or are related in some way:
Relay Therapeutics Dividend Yield
Data Unavailable
Relay Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1.07% |
| Revenue: | -67.4% | -82.05% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 26.27 |
| Upside from Last Price: | 138.16% |